PCN68 COST-UTILITY ANALYSIS OF DOCETAXEL VERSUS STANDARD REGIMEN IN THE NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST CANCER IN POLAND
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66604-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)66604-1/fulltext
Title :
PCN68 COST-UTILITY ANALYSIS OF DOCETAXEL VERSUS STANDARD REGIMEN IN THE NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST CANCER IN POLAND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66604-1&doi=10.1016/S1098-3015(10)66604-1
First page :
Section Title :
Open access? :
No
Section Order :
439